ArticleTechnology in cancer research & treatment

Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy.

Ria Nagpal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.